Cost-effectiveness Analysis of Robot-assisted Spinal Surgery

Sponsor
Beijing Jishuitan Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05388383
Collaborator
(none)
600
1
31
19.3

Study Details

Study Description

Brief Summary

With the change of lifestyle and the aging of the population, the prevalence of Lumbar disc herniation (LDH) in my country is increasing year by year, and surgery is one of the main ways to treat LDH. Surgical robots have good application prospects in the surgical treatment of patients with lumbar degenerative diseases. Studies have shown that orthopedic robot-assisted surgery has less soft tissue damage, small surgical incisions, less bleeding, high safety, and quick postoperative recovery; it reduces the risk of spinal cord and blood vessel damage that may be caused during manual operations; does not require repeated fluoroscopy To determine the position of the nail, reduce the intraoperative radiation by more than 70%, and reduce the risk of patient infection.

The current clinical research on robotics technology mainly stays in the aspects of accuracy, effectiveness, and safety. If the technology is promoted in clinical applications, the support of health economics evaluation data is urgently needed. This study hopes to apply robot-assisted technology in LDH surgical treatment through observational research design, evaluate the therapeutic effect and treatment cost of robot-assisted surgery and conventional surgery, focus on health economics evaluation, and provide treatment options for patients and medical care in the health sector. The reasonable allocation of resources and the promotion and application of this technology provide data support.

Condition or Disease Intervention/Treatment Phase
  • Device: Ti-robot

Detailed Description

Beijing Jishuitan Hospital is a pioneer in the research and application of orthopedic robotics in my country. At present, it has completed hundreds of orthopedic surgeries using the "Tianji" robotic system, and has completed a number of randomized controlled clinical trials, proving that robot-assisted surgery is effective in bone degenerative diseases Safety and accuracy in surgical treatment. Based on this platform, this research hopes to apply robot-assisted technology in the treatment of patients with lumbar intervertebral disc herniation, evaluate the therapeutic effect and treatment cost of robot-assisted surgery and conventional surgery, and focus on health economics evaluation, and provide treatment options for patients and health departments The reasonable allocation of medical resources and the promotion and application of this technology provide data support.

Study Design

Study Type:
Observational
Anticipated Enrollment :
600 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Cost-effectiveness Analysis of Robot-assisted Spinal Surgery
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
free-hand

spine surgery without robot

robot-assisted

Robot-assisted open surgery

Device: Ti-robot
Tianji ROBOT--Orthopedic surgery robot led by Beijing Jishuitan Hospital

mi

Robot-assisted minimally invasive surgery

Device: Ti-robot
Tianji ROBOT--Orthopedic surgery robot led by Beijing Jishuitan Hospital

Outcome Measures

Primary Outcome Measures

  1. COST [Up to 12 months]

    Perioperative cost

  2. Visual Analogue Scale [Up to 12 months]

    The basic method is to use a moving ruler with a length of about 10cm. One side is marked with 10 scales. The two ends are respectively "0" and "10" points. A point of 0 means no pain, and a point of 10 means the most intolerable Severe pain.

  3. Oswestry Disability Index [Up to 12 months]

    The minimum score for each item is 0 points, and the highest score is 5 points. The higher the score, the more severe the degree of dysfunction; the corresponding scores of the 10 items are accumulated. Calculate the percentage of the highest score (50 points) of the 10 items, which is the Oswestry dysfunction index. The higher the score, the more severe the patient's dysfunction.

  4. modified Japanese orthopaedic association score [Up to 12 months]

    Spinal function scoring method, including limb movement, sensory and bladder function evaluation, a total of 17 points. The higher the score, the better the recovery of spinal cord function.

  5. SF-36(Medical Outcomes Study Short-Form 36) [Up to 12 months]

    Medical Outcomes Study S hort-Form 36. There are 8 dimensions to evaluate health-related life quality (HRQOL), which are divided into two categories: physical health and physical health, namely physical function (PF), physical function (RP), physical pain (BP), General health (CH), vitality (VT), social function (SF), emotional function (RE), mental health (MH). The score is between 0-100, a high score indicates a good health.

Secondary Outcome Measures

  1. operation time [During surgery]

    operation time

  2. blood lose [During surgery]

    blood lose

  3. Radiation dose [During surgery]

    Radiation dose

  4. Complications [immediately after the surgery, up to 12 weeks]

    Complications

  5. Hospital stay [days between in and out hospital]

    total hospital stay days

  6. Deviation of screw [up to 12 months]

    The deviation between the actual position of screw and the preoperative designed position

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnose lumbar degenerative diseases and lumbar fractures

  • single-level lumbar pedicle screw internal fixation

  • Sign informed consent

Exclusion Criteria:
  • Multi-level lumbar pedicle screw internal fixation

  • QCT diagnoses severe osteoporosis (BMD <60mg/cm3).

  • Combined with abnormal coagulation function

  • Combined with serious medical diseases

  • Spinal cord injury, paraplegia

  • The doctor or nurse believes that it is not appropriate to enroll patients (such as unable to cooperate in completing the study, unable to communicate effectively, severe mental anxiety, lower limb movement disorders, etc.)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Jishuitan hospital Beijing Beijing China 100000

Sponsors and Collaborators

  • Beijing Jishuitan Hospital

Investigators

  • Study Chair: tian wei, MD,PHD, Beijing Jishuitan Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wei Tian, Director, Head of Spine department, Principal Investigator, Beijing Jishuitan Hospital
ClinicalTrials.gov Identifier:
NCT05388383
Other Study ID Numbers:
  • JST-202101
First Posted:
May 24, 2022
Last Update Posted:
May 24, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wei Tian, Director, Head of Spine department, Principal Investigator, Beijing Jishuitan Hospital

Study Results

No Results Posted as of May 24, 2022